| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/07/1996 | EP0689429B1 Cross-linked amylose as a binder/disintegrant in tablets |
| 08/07/1996 | EP0688166A4 Proteinaceous oil spill dispersant |
| 08/07/1996 | EP0476156B1 Solid oral preparation containing catechol compound |
| 08/07/1996 | CN1128531A Therapeutic compound-fatty acid conjugates |
| 08/07/1996 | CN1128496A Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth receptor |
| 08/07/1996 | CN1128495A Pharmaceutical compositions for hardly soluble active substances |
| 08/07/1996 | CN1128142A Gepirone dosage form |
| 08/07/1996 | CN1128141A Duloxetine enteric pellets |
| 08/06/1996 | US5543513 Trehalose desiccant product and dehydration therewith |
| 08/06/1996 | US5543424 Smoking substitute |
| 08/06/1996 | US5543418 Innovative technique for immunosuppresion involving administration of rapamycin loaded formed blood elements |
| 08/06/1996 | US5543393 Blend with a nonionic surfactant |
| 08/06/1996 | US5543391 Covalent microparticle-drug conjugates for biological targeting |
| 08/06/1996 | US5543390 Comprising a biologically-active compound including an antimicrobial drug. a microparticle and a cleavable linker moiety |
| 08/06/1996 | US5543389 Ointment containing antiproliferative drug bound to lipid carrier through linking and spacer groups, for rapid efficient drug delivery in treatment of skin disorders |
| 08/06/1996 | US5543158 Copolymer of polyalkylene glycol and biodegradable polymer selected from polyanhydride, polyhydroxybutyric acid, polycaprolactones, polyorthoesters, polysiloxanes, polyglycolic acid or polylactic acid or copolymer |
| 08/06/1996 | US5543157 Pharmaceutical inclusion compounds providing fast release of drug when wetted with water, e.g. body fluids |
| 08/06/1996 | US5543155 Diffusion-osmotic controlled drug-release pharmaceutical composition and process for preparing same |
| 08/06/1996 | US5543152 Liposomes having membranes of sphingomyelin and cholesterol, acidic interior containing lipophilic drug |
| 08/06/1996 | US5543150 Method of progesterone delivery and affect thereof |
| 08/06/1996 | US5543148 Mixture of solvent, gelling agent and treatment agent |
| 08/06/1996 | US5543144 Treating hypersensitivities with anti-IGE monoclonal antibodies which bind to IGE-expressing B cells but not basophils |
| 08/06/1996 | US5542935 Apparatus for making therapeutic containing gas-filled liposomes |
| 08/06/1996 | CA2014451C Sustained-release oral drug dosage form |
| 08/06/1996 | CA1338509C Viscoelastic material for ophthalmic surgery |
| 08/01/1996 | WO1996023071A2 MONOCLONAL ANTIBODIES SPECIFIC FOR DIFFERENT EPITOPES OF HUMAN gp39 AND METHODS FOR THEIR USE IN DIAGNOSIS AND THERAPY |
| 08/01/1996 | WO1996022793A1 Gene transfer for treating a connective tissue of a mammalian host |
| 08/01/1996 | WO1996022792A1 Cationic copolymers of vinylamine and vinyl alcohol for the delivery of oligonucleotides |
| 08/01/1996 | WO1996022787A1 Recombinant human alpha-fetoprotein and uses thereof |
| 08/01/1996 | WO1996022773A1 Methods and compositions for lipidization of hydrophilic molecules |
| 08/01/1996 | WO1996022767A1 Pharmaceutical compositions in the form of slow release tablets based on high molecular weight polysaccharide granules |
| 08/01/1996 | WO1996022766A1 Sulfated nonionic block copolymer surfactants as stabilizer coatings for nanoparticle compositions |
| 08/01/1996 | WO1996022764A1 Liposomes containing a corticosteroid |
| 08/01/1996 | WO1996022763A1 Liposome for destroying hiv and cells infected by said virus |
| 08/01/1996 | WO1996022762A1 Aloe vera pharmaceutical compositions |
| 08/01/1996 | CA2211833A1 Gene transfer for treating a connective tissue of a mammalian host |
| 08/01/1996 | CA2211442A1 Methods and compositions for lipidization of hydrophilic molecules |
| 08/01/1996 | CA2210482A1 Liposomes containing a corticosteroid |
| 08/01/1996 | CA2210419A1 Monoclonal antibodies specific for different epitopes of human gp39 and methods for their use in diagnosis and therapy |
| 08/01/1996 | CA2168412A1 Lysin derivatives; process for preparing the same; use thereof and compositions containing the same |
| 07/31/1996 | EP0723781A2 Transdermal formulation of xanomeline |
| 07/31/1996 | EP0723450A1 Inhibition of urinary calculi growth |
| 07/31/1996 | EP0723440A1 Therapeutic delivery compositions and methods of use thereof |
| 07/31/1996 | EP0723436A1 Multiple unit tableted dosage form i |
| 07/31/1996 | EP0723435A1 Once-a-day metoprolol oral dosage form |
| 07/31/1996 | EP0723432A1 Free flowing emulsion concentrate |
| 07/31/1996 | EP0723398A1 Superoxide dismutase and mimetics thereof |
| 07/31/1996 | EP0469074B1 Cysteine added variants il-3 and chemical modifications thereof |
| 07/31/1996 | CN1128028A N-morpholino-N-nitrosaminoacetonitril cyclodextrin inclusion complexes |
| 07/31/1996 | CN1127992A Pharmaceutical compositions containing bactericidal permeability increasing protein and a surfactant |
| 07/31/1996 | CN1127990A Encapsulated medicine |
| 07/31/1996 | CN1127989A Improved nicotine lozenge and therapeutic method for smoking cessation |
| 07/31/1996 | CN1032406C Medicinal composition contg. thrombase |
| 07/30/1996 | US5541307 Backbone modified oligonucleotide analogs and solid phase synthesis thereof |
| 07/30/1996 | US5541297 Hypoimmunogenic immunoconjugate of antibody fragment which binds to antigen associated with tumor or protozoa conjugated to drug or modified toxin and to polysaccharide or polyether through thiol-binding linker |
| 07/30/1996 | US5541287 Diagnosis using cyclic tripeptides with nitrobenzyl 1,4,7,10-tetraazacyclododecane-n,n*,n**,n***tetraacetic acid biotin conjugate formed by alkylation and multistage process |
| 07/30/1996 | US5541231 Improving storage stability of the antidepressant, bupropion hydrochloride |
| 07/30/1996 | US5541171 Orally administrable pharmaceutical composition |
| 07/30/1996 | US5541170 Orally administrable pharmaceutical compositions |
| 07/30/1996 | US5541155 Acids and acid salts and their use in delivery systems |
| 07/30/1996 | US5541110 Cloning and expression of a gene encoding bryodin 1 from Bryonia dioica |
| 07/30/1996 | US5541073 Method of diagnosing epidermis differentiation disorders in a patient using a stratum corneum-specific antibody |
| 07/30/1996 | US5540939 Encapsulating active materials |
| 07/30/1996 | US5540938 Formulations and their use in the treatment of neurological diseases |
| 07/30/1996 | US5540937 Process for preparing microspheres for the prolonged release of the LHRH hormone and its analogues, microspheres and formulations obtained |
| 07/30/1996 | US5540935 Reactive vesicle and functional substance-fixed vesicle |
| 07/30/1996 | US5540931 Antiinflammatory agents using lanolin, oil, polysorbates and cyclosporins |
| 07/30/1996 | US5540918 Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions |
| 07/30/1996 | US5540912 Viscous suspensions of controlled-release drug particles |
| 07/30/1996 | CA2072509C Cyclosporin emulsion compositions for oral administration |
| 07/25/1996 | WO1996022371A2 C-C CHEMOKINE RECEPTOR 3: CKP-3 OR Eos-L2 |
| 07/25/1996 | WO1996022325A1 Stabiliser mixture made from chromane derivatives and inert organic solvents, and microcapsules containing the said stabiliser mixture |
| 07/25/1996 | WO1996022321A1 Non-crosslinked, poly-branched polymers |
| 07/25/1996 | WO1996022303A1 Therapeutic compound - fatty acid conjugates |
| 07/25/1996 | WO1996022111A1 Local delivery and monitoring of drugs |
| 07/25/1996 | WO1996022110A2 Pharmaceutical products containing thermally-inhibited starches |
| 07/25/1996 | WO1996022109A1 Utilization of ethoxylated fatty acid esters as self-emulsifiable compounds |
| 07/25/1996 | WO1996022107A1 Dried blood factor composition comprising trehalose |
| 07/25/1996 | WO1996022088A1 Anti-inflammatory eyedrops |
| 07/25/1996 | WO1996022082A1 Valaciclovir tablets containing colloidal silicon dioxide |
| 07/25/1996 | WO1996022080A1 Pharmaceutical excipient having improved compressibility |
| 07/25/1996 | WO1996022024A1 Receptor specific transepithelial transport of immunogens |
| 07/25/1996 | WO1996011694A3 AROMATIC COMPOSITION BASED ON OLIBANAM COMBINED WITH A SYNERGIC AGENT (e.g. EUCALYPTOL, BARNEOL, ZINC, SALT, COPPER, SALT) AND USE THEREOF |
| 07/25/1996 | WO1996009805A3 Chitosan induced immunopotentiation |
| 07/25/1996 | DE19500977A1 Feste Arzneimittel mit in polymerem Material verteiltem Wirkstoff Solid pharmaceutical distributed in polymeric material agent |
| 07/25/1996 | CA2210500A1 Therapeutic compound - fatty acid conjugates |
| 07/25/1996 | CA2207086A1 G protein-coupled receptor gene |
| 07/24/1996 | EP0723015A1 Novel modified PF4 compositions and methods of use |
| 07/24/1996 | EP0722736A1 Topical composition containing an antagonist of substance P |
| 07/24/1996 | EP0722734A1 NADH and NADPH therapeutic agents for nasal, sublingual, rectal and dermal administration |
| 07/24/1996 | EP0722730A1 Controlled release oxycodone compositions |
| 07/24/1996 | EP0722720A1 Novel sugar coating composition for application to compressed medicinal tablets |
| 07/24/1996 | EP0722719A1 Process for preparing flavano-lignan preparations |
| 07/24/1996 | EP0722473A1 Metallospheres and superclusters |
| 07/24/1996 | EP0722470A1 Multifunctional organic polymers |
| 07/24/1996 | EP0722340A1 Immunological tolerance-inducing agent |
| 07/24/1996 | EP0722338A1 Protein- or peptide-cochleate vaccines and methods of immunizing using the same |
| 07/24/1996 | EP0722318A1 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 07/24/1996 | EP0722316A1 New emulsion formulation |
| 07/24/1996 | EP0722313A1 Viscoelastic compositions of fluorinated organic compounds |